Lead SALead SA

#COVID-19: SAHPRA approves the use of Chloroquine phosphate in SA

Written by: Neo Koza

The South African Health Products Regulatory Authority (SAHPRA) has given approval for Austell Pharmaceuticals to donate 500,000 Chloroquine phosphate tablets for use by the Department of Health.

Chloroquine phosphate is a drug that has been used to prevent and treat malaria and a number of bacteria.

With continued trials being done to curb COVID-19, it has been suggested that the drug could possibly reduce the number of days that patients spend in hospital and the amount of time patients remain infectious.

Austell Pharmaceuticals CEO Suhail Gani says South Africa is following the trends of several countries which have the drug included in their guidelines.

Gani says China, Belgium and South Korea have also adopted Chloroquine phosphate in their COVID-19 treatment guidelines, while the drug has been recommended for use in France, Australia and the US.

There is ongoing clinical trials being done and as they are doing trials on patients, new and more evidence is emerging....

Suhail Gani, CEO - Austell Pharmaceuticals

Chloroquine phosphate has seen in some instances to come to the rescue of some patients, reducing the number of days spent in hospital.

Suhail Gani, CEO - Austell Pharmaceuticals

The first thing to note is that less than 20% of COVID-19 cases are serious, most people get it and seems to be like flu-like symptoms and disappeared. What the guideline states at the moment is that this drug should be used in patients who have underlying conditions such as heart or lung conditions or patients suffering with severe disease.

Suhail Gani, CEO - Austell Pharmaceuticals

It is important to note that the person who takes this decision is the doctor and they will decide whether one required it or not.

Suhail Gani, CEO - Austell Pharmaceuticals

To track the latest developments around the coronavirus both in South Africa and abroad, click on this live status report from Strategix.

Click on the link below to find out more.....


This article first appeared on 702 : #COVID-19: SAHPRA approves the use of Chloroquine phosphate in SA




Read next from articles

Multi-Choice launches pop-up channel to ease Easter blues

Multi-Choice launches pop-up channel to ease Easter blues

MultiChoice SA head of corporate affairs Reggie Moalusi says the African Easter Channel will be available on channel 344 on DStv.
Read on...

Dis-Chem launches drive-through COVID-19 testing sites

Dis-Chem launches drive-through COVID-19 testing sites

The company says the tests will cost R850 each and it may take 24 to 48 hours to get your results back.
Read on...

[Active citizenry] Assist Kate Ballenden give 100 food parcels to those in need

[Active citizenry] Assist Kate Ballenden give 100 food parcels to those in need

Ballenden says she has given out 60 food hampers so far and aims to pass the 100 mark.
Read on...

[LISTEN] Fake news around COVID-19 and how to spot it

[LISTEN] Fake news around COVID-19 and how to spot it

Veteran journalist Raymond Joseph advises on how to discern whether information is reliable and factual.
Read on...

Matric revision podcast by Gauteng Education Department --- working with 702

Matric revision podcast by Gauteng Education Department --- working with 702

Pupils are able to access the podcast lessons at anytime that is suitable for them in the comfort of their homes.
Read on...

Company pledges 20,000 face shields in fight against COVID-19

Company pledges 20,000 face shields in fight against COVID-19

Dispak Group has pledged 10,000 face shields to the Gauteng Health Department and another 10,000 to healthcare workers.
Read on...